Genes Tech Group Holdings Company Limited (8257) AI Stock Analysis

• Market Cap: HK$66.00M
• Dividend Yield: N/A
• Average Volume (3M): 116.00K
• Price to Earnings (P/E): 11.0
• Beta (1Y): 1.37
• Revenue Growth: -32.47%
• EPS Growth: -74.03%
• Country: HK
• Employees: 260
• Sector: Technology
• Sector Strength: 92
• Industry: Semiconductors
• EPS (TTM): N/A
• Shares Outstanding: 1,000,000,000
• 10 Day Avg. Volume: 147,000
• 30 Day Avg. Volume: 116,000
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 65 Neutral
• Price Target: HK$0.00 ▼(-100.00% Downside)

The stock's score is driven primarily by its financial performance, showing recovery with improved operational efficiencies despite declining revenue. Technical indicators suggest a cautious outlook with neutral momentum, and the valuation appears reasonable. Lack of earnings call insights and corporate events limits a comprehensive assessment.

Genes Tech Group Holdings Company Limited Business Overview & Revenue Model

Company Description

Genes Tech Group Holdings Company Limited (8257) is a Hong Kong-based investment holding company primarily engaged in the provision of turnkey solutions in the field of semiconductor and electronics manufacturing. The company operates through various segments including the sale of used semiconductor manufacturing equipment and parts, and the provision of related services. Genes Tech Group offers comprehensive solutions that cater to the needs of semiconductor manufacturers, focusing on the refurbishment of semiconductor manufacturing equipment, which is a cost-effective alternative for clients looking to optimize their production capabilities.

How the Company Makes Money

Genes Tech Group Holdings Company Limited generates revenue through the sale of refurbished semiconductor manufacturing equipment and parts, offering an economical option for manufacturers compared to purchasing new equipment. The company also provides related services, including the installation, maintenance, and repair of semiconductor equipment. This service-oriented approach ensures ongoing revenue from support and maintenance contracts. Key revenue streams include direct sales of refurbished equipment and parts, as well as service fees from technical support and equipment maintenance. The company's ability to provide cost-effective solutions and support to semiconductor manufacturers is a significant factor contributing to its earnings.

Genes Tech Group Holdings Company Limited Financial Statement Overview

Summary

Genes Tech Group Holdings shows signs of financial recovery with improved operational efficiencies and cash flows. Despite declining revenue, cost control reflects in better margins, and the balance sheet is stable with moderate leverage.

Income Statement

The income statement shows declining revenue with a decrease from 2023 to 2024. The net profit margin in 2024 was 2.6%, which indicates low profitability. However, gross profit margin improved from 24.4% in 2023 to 28.2% in 2024, suggesting better cost control. EBIT and EBITDA margins were also positive in 2024, indicating operational improvements.

Balance Sheet

The balance sheet reflects a relatively stable financial position with a debt-to-equity ratio of 0.76 in 2024, showing moderate leverage. The equity ratio of 33.6% suggests a decent level of equity backing the assets. The return on equity improved to 3.0% in 2024, indicating some recovery in profitability.

Cash Flow

The cash flow statement shows a significant improvement in operating cash flow, turning positive in 2024. The free cash flow to net income ratio suggests strong cash generation relative to net income. Free cash flow growth was notable, indicating better capital management and liquidity.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	931.96M	1.33B	1.60B	1.50B	1.50B
Gross Profit	263.33M	325.96M	107.48M	342.17M	399.92M
EBITDA	152.99M	188.02M	-26.13M	173.37M	248.27M
Net Income	24.28M	90.64M	-80.44M	79.40M	144.20M
Balance Sheet
Total Assets	2.44B	2.10B	2.48B	2.56B	2.46B
Cash, Cash Equivalents and Short-Term Investments	194.29M	152.33M	239.68M	172.96M	96.21M
Total Debt	620.03M	635.57M	682.63M	657.80M	756.51M
Total Liabilities	1.62B	1.30B	1.77B	1.76B	1.69B
Stockholders Equity	820.48M	805.61M	712.51M	801.21M	770.05M
Cash Flow
Free Cash Flow	91.22M	-23.15M	64.43M	248.85M	26.07M
Operating Cash Flow	94.55M	-11.18M	82.49M	254.14M	63.56M
Investing Cash Flow	-2.19M	-10.91M	-17.63M	-5.19M	-37.35M
Financing Cash Flow	-55.04M	-66.58M	-11.42M	-170.79M	-63.85M

Genes Tech Group Holdings Company Limited Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 0.07
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8257, the sentiment is Neutral. The current price of 0.07 is below the 20-day moving average (MA) of 0.08, above the 50-day MA of 0.07, and below the 200-day MA of 0.07, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 44.63 is Neutral, neither overbought nor oversold. The STOCH value of 26.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:8257.

Genes Tech Group Holdings Company Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
8257	65 Neutral	HK$66.00M	11.00	3.01%	―	-32.47%	-74.03%
1967	64 Neutral	HK$186.00M	89.86	0.60%	―	6.98%	―
Sector *	57 Neutral	HK$14.02B	9.25	-2.83%	4.87%	9.29%	-48.65%
1912	49 Neutral	HK$86.75M	―	-42.18%	―	-6.19%	18.71%
1679	48 Neutral	HK$63.17M	―		―	27.19%	54.51%
0243	45 Neutral	HK$133.40M	―	-0.33%	―	2.01%	66.16%
8490	45 Neutral	HK$93.83M	68.18	-21.90%	―	-8.34%	-8828.57%